Literature DB >> 22070187

Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000.

N A Kennedy1, D N Clark, J Bauer, A M Crowe, A D Knight, R J Nicholls, J Satsangi.   

Abstract

BACKGROUND: Although population-based studies of patients with Crohn's disease (CD) suggest only a modestly increased mortality, recent data have raised concerns regarding the outcome of CD patients requiring hospitalisation. AIM: To determine the mortality and contributory factors in 1595 patients hospitalised for CD in Scotland between 1998 and 2000.
METHODS: The Scottish Morbidity Records database and linked datasets were used to assess longitudinal patient outcome, and to explore associations between 3-year mortality and age, sex, comorbidity, admission type and social deprivation. The standardised mortality ratio (SMR) at 3 years from admission was calculated with reference to the Scottish population.
RESULTS: The SMR was 3.31 (95% confidence interval 2.80-3.89). This was increased in all patients, other than those <30 years at presentation, and was highest in patients aged 50-64 years (SMR 4.84 [3.44-6.63]). On multivariate analysis, age >50, admission type, comorbidity, social deprivation and length of admission were significantly associated with mortality. Other than age, admission type was the strongest factor predictive of death. Three-year crude mortality was 0.3% for elective surgical, 8.7% for emergency surgical, 8.3% for elective nonsurgical and 12.7% for emergency nonsurgical admission (P < 0.001).
CONCLUSIONS: The study demonstrates high mortality rates in patients hospitalised during 1998-2000 for CD, especially in patients over 50. Elective surgery is associated with lower mortality than emergency surgery or medical therapy. Further study is needed to determine whether these patterns have changed following the introduction of biological treatment.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 22070187     DOI: 10.1111/j.1365-2036.2011.04906.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

1.  Association between socioeconomic status and mucosal healing in Japanese patients with ulcerative colitis: a cross-sectional study.

Authors:  Shogo Kitahata; Shinya Furukawa; Teruki Miyake; Kana Shiraishi; Kazuhiro Tange; Yu Hashimoto; Sen Yagi; Tomoyuki Ninomiya; Seiyuu Suzuki; Naozumi Shibata; Hidehiro Murakami; Katsuhisa Ohashi; Hideomi Tomida; Yasunori Yamamoto; Eiji Takeshita; Yoshio Ikeda; Yoichi Hiasa
Journal:  BMJ Open Gastroenterol       Date:  2022-10

2.  Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.

Authors:  Christopher Ma; Gordon W Moran; Eric I Benchimol; Laura E Targownik; Steven J Heitman; James N Hubbard; Cynthia H Seow; Kerri L Novak; Subrata Ghosh; Remo Panaccione; Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

3.  Crohn's disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan.

Authors:  Shigeyoshi Yasukawa; Toshiyuki Matsui; Yutaka Yano; Yuho Sato; Yasumichi Takada; Masahiro Kishi; Yoichiro Ono; Noritaka Takatsu; Takashi Nagahama; Takashi Hisabe; Fumihito Hirai; Kenshi Yao; Toshiharu Ueki; Daijiro Higashi; Kitaro Futami; Suketo Sou; Toshihiro Sakurai; Tsuneyoshi Yao; Hiroshi Tanabe; Akinori Iwashita; Masakazu Washio
Journal:  J Gastroenterol       Date:  2018-06-09       Impact factor: 7.527

4.  Hospitalizations and in-hospital mortality for inflammatory bowel disease in Brazil.

Authors:  Ana Luiza Vilar Guedes; Amanda Lopes Lorentz; Larissa Fernandes de Almeida Rios Rios; Beatriz Camara Freitas; Adriano Gutemberg Neves Dias; Ana Luísa Eckhard Uhlein; Felipe Oliveira Vieira Neto; Jobson Felipe Soares Jesus; Túlio de Sá Novaes Torres; Raquel Rocha; Vitor D Andrade; Genoile Oliveira Santana
Journal:  World J Gastrointest Pharmacol Ther       Date:  2022-01-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.